Merck & Co. Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Merck & Co. Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Others were interested in
See all stocksFrequently asked questions
To buy Merck & Co. Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Merck & Co. Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Merck & Co. Inc. is MRK:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Merck & Co. Inc. has its primary listing on New York Stock Exchange. You can trade Merck & Co. Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Merck & Co. Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Merck & Co. Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Merck & Co. Inc..